Genmab A/S (GMAB)
25.74
-0.11
(-0.43%)
USD |
NASDAQ |
Mar 19, 16:00
25.74
0.00 (0.00%)
After-Hours: 20:00
Genmab Shareholders Equity (Quarterly) : 5.847B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 30.51B |
| AbbVie, Inc. | -3.27B |
| Krystal Biotech, Inc. | 1.220B |
| Ascendis Pharma A/S | -191.23M |
| Zealand Pharma A/S | 2.332B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.87B |
| Total Liabilities (Quarterly) | 7.026B |
| Debt to Equity Ratio | 0.928 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -5.56% |